期刊文献+

血管紧张素转换酶抑制剂及珍菊降压片对2型糖尿病内皮素、一氧化氮的影响

Effects of ACEI and Zhenju Jiangya tablet on ET, NO in type 2 diabetes
暂未订购
导出
摘要 目的研究血管紧张素转换酶抑制剂(ACET)和珍菊降压片对2型糖尿病伴与不伴高血压者的血浆内皮素(ET)、一氧化氮(NO)水平的影响,指导临床药物的选择。方法 2型糖尿病患者112例,其中合并高血压(EH组)58例,Ⅰ亚组(30例)予盐酸贝那普利口服10 mg/d,每日1次;Ⅱ亚组(28例)予珍菊降压片1片/次, 每日3次。两组中血压控制不佳者,均加用双氢克尿噻25 mg/d,每日1次治疗。不伴高血压(NEH组)54例,分为Ⅲ亚组(28例),予盐酸贝那普利口服5 mg/d(ⅢA亚组)或10 mg/d(ⅢB亚组),每日1次;Ⅳ亚组(26例),仅予降糖治疗。以上各组随访用药时间均为1个月。结果①EH组中,Ⅰ亚组治疗后ET-1、NO水平分别为显著下降和升高(P<0.01),Ⅱ亚组用药后ET-1水平显著下降(P<0.05),而NO水平无明显变化。②NEH组中,Ⅲ亚组治疗后ET-1水平明显下降(P<0.05),并且NO水平显著升高(P<0.01),而无论是ⅢA亚组还是ⅢB亚组,NO水平均显著升高,ET-1均显著降低水平(P<0.05),两者间的差异无显著性。结论糖尿病伴与不伴高血压者的血浆ET、NO水平均处在不平衡状态,且ACEI的疗效优于珍菊降压片。常规或者小剂量的ACEI均能起到调节ET、NO水平的作用。 Objective To study the effects of ACEI and Zhenju Jiangya tablet on plasma ET, NO in type 2 diabetes patients with or without hypertension, and to choose the right medication at clinical practice. Methods Among 112 cases of type 2 diabetes; 58 cases constitued hypertension group(EH) which were randomly divided into ACEI group 30 cases with Lotensin 10 mg/d and Zhenju Jiangya tablet group 28 cases with 1 # tid; 54 cases were enroled in without hypertension group, ACEI group of 28 cases: Lotensin 5 mg/d 15 cases and Lotensin 10 mg/d 13 cases, and control group of 26 cases followed up for 1 month, ET, NO were tested before and after giving the treatment. Results ①In type 2 diabetes with hypertension group, Lotensin can significantly reduce and elevate the plasma levels of ET and NO (P〈0.01). Zhenju could only decrease ET (P 〈 0.05), but could not change NO. ②In type 2 diabetes without hypertension group, Lotensin could significantly decrease ET (P 〈 0.05) and obviously increase NO (P 〈0.01 ), Whatever under the dosages of 5 mg/d or 10 rag/d, Lotensin could elevate NO level and reduce ET (P 〈0.05), no difference was seen in the two dosages. Conclusion The plasma ET and NO levels are in a state of imbalance in type 2 diabetes patients with or without hypertension. To modulate the levels of ET and NO, ACEI is better than Zhenju Jiangya tablet with either routine or small dosage of ACEI. (Shanghai Med J, 2006, 29:227-229)
出处 《上海医学》 CAS CSCD 北大核心 2006年第4期227-229,共3页 Shanghai Medical Journal
关键词 2型糖尿病 血管紧张素转换酶抑制剂 珍菊降压片 内皮素 一氧化氮 Type 2 diabetes ACEI Zhenju Jiangya tablet ET NO
  • 相关文献

参考文献10

  • 1Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:a prospective study. Circulation, 2002, 105:1567-1572.
  • 2Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res, 2001, 88:E14-E22.
  • 3Ouvina SM, La Greca RD, Zanaro NL, et al. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type Ⅱ patients. Thromb Res, 2001, 102:107-114.
  • 4黄珊,张如根,吴慧萍.2型糖尿病患者血压水平与内皮素和一氧化氮的关联[J].中华糖尿病杂志(1006-6187),2004,12(2):126-127. 被引量:7
  • 5吴慧萍,黄珊,张如根.血清一氧化氮水平在2型糖尿病血管病变时的变化[J].中国临床医学,2001,8(2):163-164. 被引量:6
  • 6张如根 赵文穗 黄珊.2型糖尿病者、正常人ET、NO水平与年龄关联研究[J].中华医学研究杂志,2003,1:17-19.
  • 7张如根,项坤三,李善芳,吴建蓉,上官新红.血管紧张素转换酶抑制剂对不伴高血压2型糖尿病者动态血压观察[J].中国糖尿病杂志,2001,9(2):127-127. 被引量:4
  • 8Motley ED, Eguchi K, Gardner C, et al. Insulin-induced Akt activation is inhibited by angiotensin Ⅱ in the vasculature through protein kinase C-alpha. Hypertension, 2003, 41:775-780.
  • 9Rudich A, Tirosh A, Potashnik R, et al. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia, 1999, 42:949-957.
  • 10Caballero AE, Saouaf R, Lim SC, et al. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes, a placebo-controlled randomized clinical trial. Metabolism, 2003, 52:173-180.

二级参考文献10

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部